Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® Oral Solution Life Science Investing
AbbVie Announces European Commission Approval of RINVOQ® for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo Pharmaceutical Investing
AbbVie Announces European Commission Approval of RINVOQ® for the Treatment of Adults and Adolescents with Severe Alopecia Areata Pharmaceutical Investing
Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets Life Science Investing
Corporate Updates - NurExone appoints Mr. David Stolick to the Board of Directors Life Science Investing
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS Life Science Investing
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results Life Science Investing
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation Pharmaceutical Investing
